DVA vs UHS
DaVita vs Universal Health Services — AI-powered side-by-side comparison
VS
UHS
Universal Health Services
66
Buy
| Metric | DVA | UHS |
|---|
| AI Score |
53
|
66
|
| Price |
$177.63
|
$175.75
|
| P/E Ratio |
15.18×
|
7.15×
|
| ROE |
-114.7%
|
20.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
31.0%
|
90.7%
|
| Debt / Equity |
-14.09×
|
0.70×
|
| Dividend Yield |
0.0%
|
0.5%
|
| RSI (14) |
28.1
|
67.6
|
| Beta |
0.87
|
1.063
|
| Expected Upside |
+1.8%
|
+38.3%
|
AI Committee View
Current Innellis committee reasoning for DVA versus UHS.
UHS leads by 13 points.
UHS scores 66/100 (Buy) versus DVA at 53/100 (Watch).
DVA Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 3 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — high leverage (debt-to-equity 77.99) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 13.6 is inexpensive for the broad market — Value
- ROE of 181.2% shows genuine earnings power backing the valuation — Value
- 3 consecutive earnings beats -- consistent execution — Growth
Bear Case
- Price-to-book of 101.2x prices in significant intangible value — Value
- Debt-to-equity of 77.99 adds balance-sheet risk to the value case — Value
- RSI at 28 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
UHS Committee View
80% agreement
5 analysts
The primary driver is eps growing 29.4% yoy. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- P/E of 6.8 is inexpensive for the broad market — Value
- ROE of 20.8% shows genuine earnings power backing the valuation — Value
- EPS growing 29.4% YoY — Growth
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.